Over-expression of METCAM/MUC18 promotes the tumorigenesis of prostate cancer [22] and breast carcinoma [23, 24], but it has a minimal effect on the tumorigenesis of melanoma [25]. Here, MCAM is linked to Familial prostate cancer.